Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology. | Front Oncol | 2022 | 36686738 | PubTator, text mining | PubMed |
| Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management. | Cancers (Basel) | 2022 | 36612247 | PubTator, text mining | PubMed |
| Essential Role of Multi-Omics Approaches in the Study of Retinal Vascular Diseases. | Cells | 2022 | 36611897 | PubTator, text mining | PubMed |
| Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma. | STAR Protoc | 2022 | 36595904 | PubTator, text mining | PubMed |
| Ventilator-assisted priming of an anaesthesia circuit (VAP technique): An exploratory study. | Indian J Anaesth | 2022 | 36590184 | PubTator, text mining | PubMed |
| Transcriptional regulation of Satb1 in mouse trophoblast stem cells. | Front Cell Dev Biol | 2022 | 36589740 | PubTator, text mining | PubMed |
| Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition). | Liver Cancer | 2022 | 36589726 | PubTator, text mining | PubMed |
| Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features. | Diagn Pathol | 2022 | 36585729 | PubTator, text mining | PubMed |
| Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients. | Cancer Cell Int | 2022 | 36585652 | PubTator, text mining | PubMed |
| Can a Large Number of Transplanted Mesenchymal Stem Cells Have an Optimal Therapeutic Effect on Improving Ovarian Function? | Int J Mol Sci | 2022 | 36555651 | PubTator, text mining | PubMed |
| Tissue-Protective and Anti-Inflammatory Landmark of PRP-Treated Mesenchymal Stromal Cells Secretome for Osteoarthritis. | Int J Mol Sci | 2022 | 36555578 | PubTator, text mining | PubMed |
| Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis. | Int J Environ Res Public Health | 2022 | 36554603 | PubTator, text mining | PubMed |
| Hepatic Polarized Differentiation Promoted the Maturity and Liver Function of Human Embryonic Stem Cell-Derived Hepatocytes via Activating Hippo and AMPK Signaling Pathways. | Cells | 2022 | 36552880 | PubTator, text mining | PubMed |
| Recent Advances of Studies on Cell-Penetrating Peptides Based on Molecular Dynamics Simulations. | Cells | 2022 | 36552778 | PubTator, text mining | PubMed |
| Bioengineering Liver Organoids for Diseases Modelling and Transplantation. | Bioengineering (Basel) | 2022 | 36551002 | PubTator, text mining | PubMed |
| Pathogenesis to management of hepatocellular carcinoma. | Genes Cancer | 2022 | 36533190 | PubTator, text mining | PubMed |
| Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy. | Front Immunol | 2022 | 36532066 | PubTator, text mining | PubMed |
| The Efficiency of Direct Maturation: the Comparison of Two hiPSC Differentiation Approaches into Motor Neurons. | Stem Cells Int | 2022 | 36530489 | PubTator, text mining | PubMed |
| Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis. | Exp Mol Med | 2022 | 36509829 | PubTator, text mining | PubMed |
| mRNA therapy for myocardial infarction: A review of targets and delivery vehicles. | Front Bioeng Biotechnol | 2022 | 36507276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=22